Skip to main content
Premium Trial:

Request an Annual Quote

AltheaDx Nets $6M in Series A Financing

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Molecular diagnostics developer AltheaDx said today that it has reeled in $6 million in a Series A round of equity financing led by Telegraph Hill Partners of San Francisco.

AltheaDx will use the funds to support its partnerships with biopharmaceutical firms focused on developing companion diagnostics and biomarkers for use in making therapeutics safer, AltheaDx Co-founder and Co-CEO Magda Marquet said in a statement.

The San Diego-based firm noted that it currently has six development programs underway with biopharma partners.

"The need for biomarkers and companion diagnostics has never been more urgent as the biopharma industry is concentrating significant resources on the development of targeted therapeutics, specifically in oncology," AltheaDx Co-founder and Co-CEO Francois Ferré added. "As more and more therapeutics focus on a specific gene abnormality, it becomes essential to know which patient carries it to enhance the chance of a positive therapeutic response."

AltheaDx offers end-to-end biomarker discovery and development services. It offers RNA expression profiling using Affymetrix microarrays, PCR-based quantification, RNA-QC assays to pre-qualify samples, and DNA genotyping to identify SNPs.

It also has proprietary biomarker panels for use in diagnosis and prognosis of prostate cancer, diagnosis of childhood cancer, and custom gene panels for targeted oncology therapeutics.

The Scan

Shape of Them All

According to BBC News, researchers have developed a protein structure database that includes much of the human proteome.

For Flu and More

The Wall Street Journal reports that several vaccine developers are working on mRNA-based vaccines for influenza.

To Boost Women

China's Ministry of Science and Technology aims to boost the number of female researchers through a new policy, reports the South China Morning Post.

Science Papers Describe Approach to Predict Chemotherapeutic Response, Role of Transcriptional Noise

In Science this week: neural network to predict chemotherapeutic response in cancer patients, and more.